These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 37515109)

  • 41. Glucosyl hesperidin prevents influenza a virus replication in vitro by inhibition of viral sialidase.
    Saha RK; Takahashi T; Suzuki T
    Biol Pharm Bull; 2009 Jul; 32(7):1188-92. PubMed ID: 19571383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulfatide is required for efficient replication of influenza A virus.
    Takahashi T; Murakami K; Nagakura M; Kishita H; Watanabe S; Honke K; Ogura K; Tai T; Kawasaki K; Miyamoto D; Hidari KI; Guo CT; Suzuki Y; Suzuki T
    J Virol; 2008 Jun; 82(12):5940-50. PubMed ID: 18417587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effect of low-concentration chlorine dioxide gas against influenza A virus infection.
    Ogata N; Shibata T
    J Gen Virol; 2008 Jan; 89(Pt 1):60-67. PubMed ID: 18089729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. THE PROTECTION OF MICE AGAINST INFECTION WITH AIR-BORNE INFLUENZA VIRUS BY MEANS OF PROPYLENE GLYCOL VAPOR.
    Robertson OH; Loosli CG; Puck TT; Bigg E; Miller BF
    Science; 1941 Dec; 94(2452):612-3. PubMed ID: 17740060
    [No Abstract]   [Full Text] [Related]  

  • 45. Virucidal effects of the steam distillate from Houttuynia cordata and its components on HSV-1, influenza virus, and HIV.
    Hayashi K; Kamiya M; Hayashi T
    Planta Med; 1995 Jun; 61(3):237-41. PubMed ID: 7617766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subchronic nose-only inhalation study of propylene glycol in Sprague-Dawley rats.
    Suber RL; Deskin R; Nikiforov I; Fouillet X; Coggins CR
    Food Chem Toxicol; 1989 Sep; 27(9):573-83. PubMed ID: 2807102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibacterial and antifungal properties of propylene glycol, hexylene glycol, and 1,3-butylene glycol in vitro.
    Kinnunen T; Koskela M
    Acta Derm Venereol; 1991; 71(2):148-50. PubMed ID: 1675525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiviral Effect of Propylene Glycol against Envelope Viruses in Spray and Volatilized Forms.
    Hirama Y; Onishi S; Shibata R; Ishida H; Mori T; Ota N
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
    Krishna G; Pillai VS; Veettil MV
    Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of the oral cavity in SARS-CoV-2- and other viral infections.
    Hoffmann D
    Clin Oral Investig; 2023 Jun; 27(Suppl 1):15-22. PubMed ID: 37310513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review.
    Wilson NM; Norton A; Young FP; Collins DW
    Anaesthesia; 2020 Aug; 75(8):1086-1095. PubMed ID: 32311771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An updated and comprehensive review of the antiviral potential of essential oils and their chemical constituents with special focus on their mechanism of action against various influenza and coronaviruses.
    Wani AR; Yadav K; Khursheed A; Rather MA
    Microb Pathog; 2021 Mar; 152():104620. PubMed ID: 33212200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minimum Sizes of Respiratory Particles Carrying SARS-CoV-2 and the Possibility of Aerosol Generation.
    Lee BU
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.
    Huang T; Sun L; Kang D; Poongavanam V; Liu X; Zhan P; Menéndez-Arias L
    Adv Exp Med Biol; 2021; 1322():219-260. PubMed ID: 34258743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
    Hosoki K; Chakraborty A; Sur S
    J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology.
    Zhou Y; Wang H; Yang L; Wang Q
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Viral Envelope Membrane: A Special Entry Pathway and a Promising Drug Target.
    Palombi N; Brai A; Gerace M; Di Maria S; Orofino F; Corelli F
    Curr Med Chem; 2021 Oct; 28(34):6957-6976. PubMed ID: 33602071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.